Termination of Acute Stroke Studies Involving Selfotel Treatment. ASSIST Steering Committed.
Davis
S M
SM
Department of Neurology, Melbourne Neuroscience Centre, Royal Melbourne Hospital, Victoria, Australia.
Albers
G W
GW
Diener
H C
HC
Lees
K R
KR
Norris
J
J
D000368:Aged; D002545:Brain Ischemia / Q000188:drug therapy; D002561:Cerebrovascular Disorders / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010875:Pipecolic Acids / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D016896:Treatment Outcome
D018691:Excitatory Amino Acid Antagonists; D010875:Pipecolic Acids; C053672:selfotel